skip to main content
back

Press Releases

19 Aug 2002

United Therapeutics Chairman and CEO Adopts 10b5-1 Trading Plan
Download pdf

16 Aug 2002

Michael P. Joseph Joins United Therapeutics Board of Directors as Audit Committee Chairman
Download pdf

08 Aug 2002

United Therapeutics Reports Second Quarter 2002 Financial Results
Download pdf

01 Aug 2002

United Therapeutics to Announce Second Quarter 2002 Financial Results Before Market Open on August 8, 2002
Download pdf

22 May 2002

United Therapeutics Receives FDA Approval for Remodulin™ toTreat Pulmonary Arterial Hypertension
Download pdf

09 May 2002

United Therapeutics Reports First Quarter 2002 Financial Results
Download pdf

06 May 2002

United Therapeutics to Announce First Quarter 2002 Financial Results After Close of Market on May 9, 2002
Download pdf

25 Feb 2002

United Therapeutics Reports 2001 Annual Financial Results
Download pdf

19 Feb 2002

Canadian Health Authority Accepts Remodulin New Drug Submission For Priority Review
Download pdf

11 Feb 2002

United Therapeutics Receives FDA Approvable Letter for Remodulin to Treat Pulmonary Arterial Hypertension
Download pdf

11 Jan 2002

United Therapeutics Announces Appointment of Raymond Kurzweil to Board of Directors
Download pdf

04 Jan 2002

United Therapeutics Subsidiary Contracts with International Space Station
Download pdf

(Showing 493 – 504 of 522)